Bio-Techne
TECH
#1989
Rank
A$14.46 B
Marketcap
A$92.86
Share price
-2.93%
Change (1 day)
-18.59%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Number of shares outstanding for Bio-Techne (TECH)

Number of shares outstanding as of December 2025 : 155,464,000

According to Bio-Techne's latest financial reports and stock price the company's current number of shares outstanding is 155,464,000. At the end of 2025 the company had 155,464,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Bio-Techne from 2022 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.15 B-1.87%
20240.15 B0.57%
20230.15 B0.33%
20220.15 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Thermo Fisher Scientific
TMO
378,000,000 143.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
26,923,000-82.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
287,170,000 84.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
710,700,000 357.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
216,871,000 39.50%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
1,058,000,000 580.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
52,403,000-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA